Gainers

• AMN Healthcare Services (NYSE:AMN) stock increased by 25.6% to $28.2 during Friday's regular session. The market value of their outstanding shares is at $867.8 million. The company's, Q1 earnings came out yesterday.
• Inovio Pharmaceuticals (NASDAQ:INO) stock rose 25.28% to $1.72. The company's market cap stands at $111.7 million.
• Maravai LifeSciences (NASDAQ:MRVI) stock moved upwards by 23.22% to $4.86. The market value of their outstanding shares is at $571.3 million. The company's, Q1 earnings came out yesterday.
• Traws Pharma (NASDAQ:TRAW) stock moved upwards by 22.35% to $2.08. The market value of their outstanding shares is at $17.2 million.
• Co-Diagnostics (NASDAQ:CODX) shares rose 20.72% to $2.33. The company's market cap stands at $4.0 million.
• PTC Therapeutics (NASDAQ:PTCT) shares increased by 20.31% to $77.59. The market value of their outstanding shares is at $5.3 billion. As per the press release, Q1 earnings came out yesterday.

Losers

• AIM ImmunoTech (AMEX:AIM) stock decreased by 35.1% to $0.36 during Friday's regular session. The market value of their outstanding shares is at $2.2 million.
• Artivion (NYSE:AORT) stock decreased by 26.6% to $26.0. The company's market cap stands at $1.6 billion. As per the press release, Q1 earnings came out yesterday.
• Sensus Healthcare (NASDAQ:SRTS) shares declined by 26.53% to $3.02. The market value of their outstanding shares is at $67.6 million. As per the news, the Q1 earnings report came out yesterday.
• Akanda (NASDAQ:AKAN) shares declined by 25.68% to $27.64. The company's market cap stands at $19.8 million.
• Amphastar Pharma (NASDAQ:AMPH) stock fell 23.6% to $18.36. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q1 earnings came out yesterday.
• Outset Medical (NASDAQ:OM) shares fell 20.3% to $3.73. The company's market cap stands at $86.7 million. As per the press release, Q1 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.